Abcellera Biologics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $6,507 | $7,323 | $9,954 | $9,179 |
Gross Profit | -31,788 | -30,714 | 3,188 | 70 |
EBITDA | -51,877 | -56,932 | -48,128 | -58,517 |
EBIT | -90,172 | -94,969 | -54,894 | -67,626 |
Net Income | -51,107 | -36,930 | -40,610 | -47,150 |
Net Change In Cash | 6,507 | 7,323 | 9,954 | 9,179 |
Free Cash Flow | -47,398 | -49,255 | -65,848 | -34,042 |
Cash | 126,640 | 173,312 | 148,572 | 133,320 |
Basic Shares | 294,851 | 294,217 | 292,723 | 290,046 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $38,025 | $485,424 | $11,611 | $233,155 |
Gross Profit | 38,025 | 418,988 | 11,611 | 206,012 |
EBITDA | -192,158 | 272,201 | -154 | 169,615 |
EBIT | -223,052 | 239,099 | -2,001 | 164,344 |
Net Income | -146,398 | 158,519 | -2,210 | 118,918 |
Net Change In Cash | 38,025 | 485,424 | 11,611 | 233,155 |
Cost of Revenue | -76,893 | -91,549 | ||
Free Cash Flow | -121,384 | 204,700 | 186,132 | 8,017 |
Cash | 133,320 | 386,535 | 476,142 | 594,116 |
Basic Shares | 289,166 | 314,827 | 318,294 | 269,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.17 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.17 |
